SGLT-2-Inhibitors

Pfister, O

Pfister, O (reprint author), Univ Spital Basel, Klin Kardiol, Spitalstr 21,Petersgraben 4, CH-4031 Basel, Switzerland.

THERAPEUTISCHE UMSCHAU, 2017; 74 (8): 462

Abstract

Diabetes mellitus doubles the risk of cardiovascular disease with a prevalent increase of new onset heart failure. SGLT2-inhibitors significantly redu......

Full Text Link